Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (5)
• Solid tissue (non viable) (1)
• Stool (3)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Not applicable (5)

Storage Temperature

• RT (1)
• -35°C to -18°C (2)
• -85°C to -60°C (7)

Associated Data

• Biomarker datasets (2)
• Clinical records (5)
• Followup records (5)
• Freezer temperature logs (5)
• Genomic datasets (2)
• Microbiological results (2)
• Participant Ethnicity (3)
• Pre-analytical data (2)
• Quality indicators (2)
• Survey data (4)
• Treatment records (4)

Timeframe

• Immediate (2)
• 0 - 3 months (6)
• 3 - 6 months (2)
• > 6 months (4)

Participant Count

• 11 - 100 (7)

Sex

• Both sexes (7)

Age Range

• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (2)
• Adolescent (12 - 18 years) (4)
• Young adult (18 - 40 years) (2)
• Adult (> 40 years) (4)

Biobank Services

• Ability to recontact (2)
• Cell culture (2)
• Data analytics (1)
• Digital imaging (2)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (4)

Collection Type

• Case-control (1)
• Clinical Trial (1)
• Cohort (1)
• Cross-sectional (4)
• Disease specific (1)
• Longitudinal (1)

Consent Restriction

• No Commercial restriction (7)
• No Disease area restriction (7)
• No Export restriction (7)
• No Genetic analysis restriction (6)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (6)
• No Scope of use restriction (5)

Collection Status

• Completed (3)
• In progress (4)
• Not-started (2)

Access Condition

• Open to applicants (3)
• Open in response to specific calls (1)
• Open only through collaboration (3)

Country

• Belgium (1)
• India (1)
• Peru (2)
• Spain (1)
• Switzerland (1)
• United States (2)

County